GSK "ANTEY", Saint Petersburg

Economic indicators

Net profit (RAS) of GSK ANTEY grew over 2020 by 4.48% to 70.00 thousand RUB from 67.00 thousand RUB over 2019, the company informed.

Revenue increased in the accounting period by 4.48% to 70.00 thousand RUB from 67.00 thousand RUB over 2019; sales profit went up by 4.48% to 70.00 thousand RUB from 67.00 thousand RUB.

Net profit (RAS) of GSK ANTEY grew over 2019 by 8.00% to 54.00 thousand RUB from 50.00 thousand RUB over 2018, the company informed.

Revenue increased in the accounting period by 6.35% to 67.00 thousand RUB from 63.00 thousand RUB over 2018; sales profit went up by 6.35% to 67.00 thousand RUB from 63.00 thousand RUB.

Net profit (RAS) of GSK ANTEY over 2018 was the same as in 2017 reaching 50.00 thousand RUB, the company informed.

Revenue remained in the accounting period at the same level and made up 63.00 thousand RUB compared to 63.00 thousand RUB 63.00 thousand RUB; sales profit matched the previous year’s result amounting to 63.00 thousand RUB.

Net profit (RAS) of GSK Antey made up 0 RUB over 2013 compared to 35.00 thousand RUB over 2012, the company informed.

Revenue decreased in the accounting period Infinity times to 0.00 thousand RUB from 44.00 thousand RUB in 2012; sales profit made up 0 RUB compared to 44.00 thousand RUB.

Companies in the region

• OTRAZHENIE
• SGK
• EVROREZERVSISTEMY
• PRIMAVERA
• KOMPANIYA MEGASTROY